Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens

Biochimica et Biophysica Acta - Biomembranes

Volumn 1848, Issue 11, 2015, Pages 3047-3054

  LaRock, Christopher N ^a   Nizet, Victor ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Antimicrobial peptide; Cathelicidin; Defensin; LL 37; Streptococcus virulence factors, innate immunity

Indexed keywords

CATIONIC ANTIMICROBIAL PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; CARRIER PROTEIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; HUMAN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; ANIMAL; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STREPTOCOCCAL INFECTIONS; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL VIABILITY; PROTEOLYSIS; SIGNAL TRANSDUCTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 84943661837     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2015.02.010     Document Type: Review

References (97)

1. J.R. Carapetis, A.C. Steer, E.K. Mulholland, and M. Weber The global burden of group A streptococcal diseases Lancet Infect. Dis. 5 2005 685 694
2. M.J. Walker, T.C. Barnett, J.D. McArthur, J.N. Cole, C.M. Gillen, A. Henningham, K.S. Sriprakash, M.L. Sanderson-Smith, and V. Nizet Disease manifestations and pathogenic mechanisms of group a Streptococcus Clin. Microbiol. Rev. 27 2014 264 301
3. C.J. Baker The spectrum of perinatal group B streptococcal disease Vaccine 31 Suppl. 4 2013 D3 D6
4. P. Sendi, L. Johansson, and A. Norrby-Teglund Invasive group B streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections Infection 36 2008 100 111
5. J.P. Lynch III, and G.G. Zhanel Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention Sem Resp. Crit. Care. Med. 30 2009 189 209
6. J.J. Drijkoningen, and G.G. Rohde Pneumococcal infection in adults: burden of disease Clin. Microbiol. Infect. 20 Suppl. 5 2014 45 51
7. R. Bals, X. Wang, M. Zasloff, and J.M. Wilson The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface Proc. Natl. Acad. Sci. U. S. A. 95 1998 9541 9546
8. E.D. Stolzenberg, G.M. Anderson, M.R. Ackermann, R.H. Whitlock, and M. Zasloff Epithelial antibiotic induced in states of disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 8686 8690
9. R.A. Dorschner, V.K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G.H. Gudmundsson, and R.L. Gallo Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus J. Invest. Derm. 117 2001 91 97
10. L.A. Vega, and M.G. Caparon Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal Mol. Microbiol. 85 2012 1119 1132
11. J.D. Heilborn, M.F. Nilsson, G. Kratz, G. Weber, O. Sørensen, N. Borregaard, and M. Ståhle-Bäckdahl The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium J. Invest. Derm. 120 2003 379 389
12. D. Yang, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M. Wang, J. Wooters, J.J. Oppenheim, and O. Chertov LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
13. J. Yu, N. Mookherjee, K. Wee, D.M.E. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R.E.W. Hancock Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways J. Immunol. 179 2007 7684 7691
14. M. Zaiou, V. Nizet, and R.L. Gallo Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence J. Invest. Derm. 120 2003 810 816
15. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D.S. Weiss, Y. Weinrauch, and A. Zychlinsky Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
16. M. von Köckritz-Blickwede, O. Goldmann, P. Thulin, K. Heinemann, A. Norrby-Teglund, M. Rohde, and E. Medina Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation Blood 111 2008 3070 3080
17. M.G.J.L. Habets, D.E. Rozen, and M.A. Brockhurst Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition Proc. Royal Soc. B: Biol. Sci. 279 279 2012 3803 3811
18. A.M. Timmer, J.C. Timmer, M.A. Pence, L.-C. Hsu, M. Ghochani, T.G. Frey, M. Karin, G.S. Salvesen, and V. Nizet Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis J. Biol. Chem. 284 2009 862 871
19. P. Sumby, K.D. Barbian, D.J. Gardner, A.R. Whitney, D.M. Welty, R.D. Long, J.R. Bailey, M.J. Parnell, N.P. Hoe, and G.G. Adams Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response Proc. Natl. Acad. Sci. U. S. A. 102 2005 1679 1684
20. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken, D.L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zügel, R.L. Gallo, D. Eisenberg, M. Hewison, B.W. Hollis, J.S. Adams, B.R. Bloom, and R.L. Modlin Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
21. C.M. Ernst, P. Staubitz, N.N. Mishra, S.-J. Yang, G. Hornig, H. Kalbacher, A.S. Bayer, D. Kraus, and A. Peschel The bacterial defensin resistance protein mprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion PLoS Pathog. 5 2009 e1000660
22. R. Saar-Dover, A. Bitler, R. Nezer, L. Shmuel-Galia, A. Firon, E. Shimoni, P. Trieu-Cuot, and Y. Shai d-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B Streptococcus by increasing the cell wall density PLoS Pathog. 8 2012 e1002891
23. W. Vollmer, and A. Tomasz Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae Infect. Immun. 70 2002 7176 7178
24. N. Fittipaldi, T. Sekizaki, D. Takamatsu, M. De La Cruz Domínguez-Punaro, J. Harel, N.K. Bui, W. Vollmer, and M. Gottschalk Significant contribution of the pgdA gene to the virulence of Streptococcus suis Mol. Microbiol. 70 2008 1120 1135
25. J.P. Allen, and M.N. Neely CpsY influences Streptococcus iniae cell wall adaptations important for neutrophil intracellular survival Infect. Immun. 80 2012 1707 1715
26. M.I. Crisóstomo, W. Vollmer, A.S. Kharat, S. Inhülsen, F. Gehre, S. Buckenmaier, and A. Tomasz Attenuation of penicillin resistance in a peptidoglycan O-acetyl transferase mutant of Streptococcus pneumoniae Mol. Microbiol. 61 2006 1497 1509
27. M. Kovács, A. Halfmann, I. Fedtke, M. Heintz, A. Peschel, W. Vollmer, R. Hakenbeck, and R. Brückner A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae J. Bacteriol. 188 2006 5797 5805
28. F. Wartha, K. Beiter, B. Albiger, J. Fernebro, A. Zychlinsky, S. Normark, and B. Henriques-Normark Capsule and d-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps Cell. Microbiol. 9 2007 1162 1171
29. S.A. Kristian, V. Datta, C. Weidenmaier, R. Kansal, I. Fedtke, A. Peschel, R.L. Gallo, and V. Nizet d-alanylation of teichoic acids promotes group A streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion J. Bacteriol. 187 2005 6719 6725
30. C. Poyart, E. Pellegrini, M. Marceau, M. Baptista, F. Jaubert, M.-C. Lamy, and P. Trieu-Cuot Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells Mol. Microbiol. 49 2003 1615 1625
31. N. Fittipaldi, T. Sekizaki, D. Takamatsu, J.e. Harel, M. de la Cruz Domínguez-Punaro, S. Von Aulock, C. Draing, C. Marois, M.n. Kobisch, and M. Gottschalk d-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis Infect. Immun. 76 2008 3587 3594
32. Y. Mazda, M. Kawada-Matsuo, K. Kanbara, Y. Oogai, Y. Shibata, Y. Yamashita, S. Miyawaki, and H. Komatsuzawa Association of CiaRH with resistance of Streptococcus mutans to antimicrobial peptides in biofilms Mol. Oral Microbiol. 27 2012 124 135
33. K.H. Cox, E. Ruiz-Bustos, H.S. Courtney, J.B. Dale, M.A. Pence, V. Nizet, R.K. Aziz, I. Gerling, S.M. Price, and D.L. Hasty Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes PLoS One 4 2009 e5366
34. X. Lauth, M. von Köckritz-Blickwede, C.W. McNamara, S. Myskowski, A.S. Zinkernagel, B. Beall, P. Ghosh, R.L. Gallo, and V. Nizet M1 protein allows group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition J Innate Immun. 1 2009 202 214
35. M.A. Pence, S.H. Rooijakkers, A.L. Cogen, J.N. Cole, A. Hollands, R.L. Gallo, and V. Nizet Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus J. Innate Immun. 2 2010 587 595
36. Nina M. van Sorge, Jason N. Cole, K. Kuipers, A. Henningham, Ramy K. Aziz, A. Kasirer-Friede, L. Lin, Evelien T.M. Berends, Mark R. Davies, G. Dougan, F. Zhang, S. Dahesh, L. Shaw, J. Gin, M. Cunningham, Joseph A. Merriman, J. Hütter, B. Lepenies, Suzan H.M. Rooijakkers, R. Malley, Mark J. Walker, Sanford J. Shattil, Patrick M. Schlievert, B. Choudhury, and V. Nizet The classical lancefield antigen of group A Streptococcus is a virulence determinant with implications for vaccine design Cell Host Microbe 15 2014 29 740
37. E. Swiatlo, F.R. Champlin, S.C. Holman, W.W. Wilson, and J.M. Watt Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae Infect. Immun. 70 2002 412 415
38. E.S. Lysenko, J. Gould, R. Bals, J.M. Wilson, and J.N. Weiser Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract Infect. Immun. 68 2000 1664 1671
39. M.R. Wessels, A.E. Moses, J.B. Goldberg, and T.J. DiCesare Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci Proc. Natl. Acad. Sci. U. S. A. 88 1991 8317 8321
40. J.N. Cole, M.A. Pence, M. von Köckritz-Blickwede, A. Hollands, R.L. Gallo, M.J. Walker, and V. Nizet M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus MBio 1 2010 (e00191-00110)
41. J.T. Buchanan, J.A. Stannard, X. Lauth, V.E. Ostland, H.C. Powell, M.E. Westerman, and V. Nizet Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development Infect. Immun. 73 2005 6935 6944
42. E. Llobet, J.M. Tomas, and J.A. Bengoechea Capsule polysaccharide is a bacterial decoy for antimicrobial peptides Microbiology 154 2008 3877 3886
43. K. Beiter, F. Wartha, R. Hurwitz, S. Normark, A. Zychlinsky, and B. Henriques-Normark The capsule sensitizes Streptococcus pneumoniae to α-defensins human neutrophil proteins 1 to 3 Infect. Immun. 76 2008 3710 3716
44. P. Åkesson, A.G. Sjöholm, and L. Björck Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function J. Biol. Chem. 271 1996 1081 1088
45. I.-M. Frick, P. Åkesson, M. Rasmussen, A. Schmidtchen, and L. Björck SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides J. Biol. Chem. 278 2003 16561 16566
46. B.A. Fernie-King, D.J. Seilly, M.J. Binks, K.S. Sriprakash, and P.J. Lachmann Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities Microb. Infect. 9 2007 300 307
47. D. Smyth, A. Cameron, M.R. Davies, C. McNeilly, L. Hafner, S. Sriprakash, and D.J. McMillan DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37 Infect. Immun. 82 2014 2337 2344
48. P. Ghosh The nonideal coiled coil of M protein and its multifarious functions in pathogenesis Bacterial Adhesion 2011 Springer 197 211
49. H.C. Maisey, D. Quach, M.E. Hensler, G.Y. Liu, R.L. Gallo, V. Nizet, and K.S. Doran A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence FASEB J. 22 2008 1715 1724
50. S. Papasergi, S. Brega, M.-Y. Mistou, A. Firon, V. Oxaran, R. Dover, G. Teti, Y. Shai, P. Trieu-Cuot, and S. Dramsi The GBS PI-2a pilus is required for virulence in mice neonates PLoS One 6 2011 e18747
51. A. Hamilton, D.L. Popham, D.J. Carl, X. Lauth, V. Nizet, and A.L. Jones Penicillin-binding protein 1a promotes resistance of group B Streptococcus to antimicrobial peptides Infect. Immun. 74 2006 6179 6187
52. A.L. Jones, R.H. Mertz, D.J. Carl, and C.E. Rubens A streptococcal penicillin-binding protein is critical for resisting innate airway defenses in the neonatal lung J. Immunol. 179 2007 3196 3202
53. W.M. Shafer, X.-D. Qu, A.J. Waring, and R.I. Lehrer Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family Proc. Natl. Acad. Sci. U. S. A. 95 1998 1829 1833
54. D. Zähner, X. Zhou, S.T. Chancey, J. Pohl, W.M. Shafer, and D.S. Stephens Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother. 54 2010 3516 3519
55. J. Hoskins, W.E. Alborn, J. Arnold, L.C. Blaszczak, S. Burgett, B.S. DeHoff, S.T. Estrem, L. Fritz, D.-J. Fu, W. Fuller, C. Geringer, R. Gilmour, J.S. Glass, H. Khoja, A.R. Kraft, R.E. Lagace, D.J. LeBlanc, L.N. Lee, E.J. Lefkowitz, J. Lu, P. Matsushima, S.M. McAhren, M. McHenney, K. McLeaster, C.W. Mundy, T.I. Nicas, F.H. Norris, M. O'Gara, R.B. Peery, G.T. Robertson, P. Rockey, P.-M. Sun, M.E. Winkler, Y. Yang, M. Young-Bellido, G. Zhao, C.A. Zook, R.H. Baltz, S.R. Jaskunas, P.R. Rosteck, P.L. Skatrud, and J.I. Glass Genome of the bacterium Streptococcus pneumoniae strain R6 J. Bacteriol. 183 2001 5709 5717
56. J.A. Majchrzykiewicz, O.P. Kuipers, and J.J.E. Bijlsma Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin Antimicrob. Agents Chemother. 54 2010 440 451
57. J. Ouyang, X.-L. Tian, J. Versey, A. Wishart, and Y.-H. Li The BceABRS four-component system regulates the bacitracin-induced cell envelope stress response in Streptococcus mutans Antimicrob. Agents Chemother. 54 2010 3895 3906
58. C.Y.M. Okumura, E.L. Anderson, S. Döhrmann, D.N. Tran, J. Olson, U. von Pawel-Rammingen, and V. Nizet IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus MBio 4 2013 e00499-13
59. T.C. Barnett, D. Liebl, L.M. Seymour, C.M. Gillen, J.Y. Lim, C.N. LaRock, M.R. Davies, B.L. Schulz, V. Nizet, and R.D. Teasdale The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication Cell Host Microbe 14 2013 675 682
60. D.C. Nelson, J. Garbe, and M. Collin Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins Biol. Chem. 392 2011 1077 1088
61. A. Schmidtchen, I.-M. Frick, E. Andersson, H. Tapper, and L. Björck Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37 Mol. Microbiol. 46 2002 157 168
62. I.-M. Frick, S.L. Nordin, M. Baumgarten, M. Morgelin, O.E. Schmidtchen, A.I. Olin, and A. Egesten Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes J. Immunol. 187 2011 4300 4309
63. A. Schmidtchen, I.-M. Frick, and L. Björck Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α-defensin Mol. Microbiol. 39 2001 708 713
64. W. Baranska-Rybak, A. Sonesson, R. Nowicki, and A. Schmidtchen Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids J. Antimicrob. Chemother. 57 2006 260 265
65. P. Nyberg, M. Rasmussen, and L. Björck α2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37 J. Biol. Chem. 279 2004 52820 52823
66. H. Sun, U. Ringdahl, J.W. Homeister, W.P. Fay, N.C. Engleberg, A.Y. Yang, L.S. Rozek, X. Wang, U. Sjobring, and D. Ginsburg Plasminogen is a critical host pathogenicity factor for group A streptococcal infection Science 305 2004 1283 1286
67. A. Hollands, D. Gonzalez, E. Leire, C. Donald, R.L. Gallo, M. Sanderson-Smith, P.C. Dorrestein, and V. Nizet A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides J. Biol. Chem. 287 2012 40891 40897
68. P. Kuusela, M. Ullberg, O. Saksela, and G. Kronvall Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci Infect. Immun. 60 1992 196 201
69. J.N. Cole, J.D. McArthur, F.C. McKay, M.L. Sanderson-Smith, A.J. Cork, M. Ranson, M. Rohde, A. Itzek, H. Sun, and D. Ginsburg Trigger for group A streptococcal M1T1 invasive disease FASEB J. 20 2006 1745 1747
70. L. Johansson, P. Thulin, P. Sendi, E. Hertzen, A. Linder, P. Akesson, D.E. Low, B. Agerberth, and A. Norrby-Teglund Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans Infect. Immun. 76 2008 3399 3404
71. M.W. Bader, S. Sanowar, M.E. Daley, A.R. Schneider, U. Cho, W. Xu, R.E. Klevit, H. Le Moual, and S.I. Miller Recognition of antimicrobial peptides by a bacterial sensor kinase Cell 122 2005 461 472
72. I. Gryllos, H.J. Tran-Winkler, M.-F. Cheng, H. Chung, R. Bolcome, W. Lu, R.I. Lehrer, and M.R. Wessels Induction of group A Streptococcus virulence by a human antimicrobial peptide Proc. Natl. Acad. Sci. U. S. A. 105 2008 16755 16760
73. T.L. Dalton, and J.R. Scott CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes J. Bacteriol. 186 2004 3928 3937
74. B.J. Froehlich, C. Bates, and J.R. Scott Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37 J. Bacteriol. 191 2009 673 677
75. A. Hollands, M.A. Pence, A.M. Timmer, S.R. Osvath, L. Turnbull, C.B. Whitchurch, M.J. Walker, and V. Nizet Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A Streptococcus M1T1 clone J. Infect. Dis. 202 2010 11 19
76. H.J. Tran-Winkler, J.F. Love, I. Gryllos, and M.R. Wessels Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus PLoS Pathog. 7 2011 e1002361
77. M.C. Lamy, M. Zouine, J. Fert, M. Vergassola, E. Couve, E. Pellegrini, P. Glaser, F. Kunst, T. Msadek, and P. Trieu-Cuot CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence Mol. Microbiol. 54 2004 1250 1268
78. M.R. Graham, L.M. Smoot, C.A.L. Migliaccio, K. Virtaneva, D.E. Sturdevant, S.F. Porcella, M.J. Federle, G.J. Adams, J.R. Scott, and J.M. Musser Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling Proc. Natl. Acad. Sci. U. S. A. 99 2002 13855 13860
79. P. Sumby, A.R. Whitney, E.A. Graviss, F.R. DeLeo, and J.M. Musser Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity PLoS Pathog. 2 2006 e5
80. D.C. Klinzing, N. Ishmael, J.C.D. Hotopp, H. Tettelin, K.R. Shields, L.C. Madoff, and K.M. Puopolo The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus Microbiology 159 2013 1521 1534
81. D. Quach, N.M. van Sorge, S.A. Kristian, J.D. Bryan, D.W. Shelver, and K.S. Doran The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses J. Bacteriol. 191 2009 2023 2032
82. P. Suntharalingam, M.D. Senadheera, R.W. Mair, C.M. Lévesque, and D.G. Cvitkovitch The LiaFSR system regulates the cell envelope stress response in Streptococcus mutans J. Bacteriol. 191 2009 2973 2984
83. T. Mascher, M. Heintz, D. Zähner, M. Merai, and R. Hakenbeck The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in β-lactam resistance J. Bacteriol. 188 2006 1959 1968
84. V. Nizet, T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R.A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R.L. Gallo Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 414 2001 454 457
85. M. Li, Y. Lai, A.E. Villaruz, D.J. Cha, D.E. Sturdevant, and M. Otto Gram-positive three-component antimicrobial peptide-sensing system Proc. Natl. Acad. Sci. U. S. A. 104 2007 9469 9474
86. M. Pietiäinen, M. Gardemeister, M. Mecklin, S. Leskelä, M. Sarvas, and V.P. Kontinen Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems Microbiology 151 2005 1577 1592
87. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R.L. Gallo, and D.Y.M. Leung Endogenous antimicrobial peptides and skin infections in atopic dermatitis New Engl. JJ. Med. 347 2002 1151 1160
88. P.H.A. Lee, T. Ohtake, M. Zaiou, M. Murakami, J.A. Rudisill, K.H. Lin, and R.L. Gallo Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection Proc. Natl. Acad. Sci. U. S. A. 102 2005 3750 3755
89. N.H. Salzman, D. Ghosh, K.M. Huttner, Y. Paterson, and C.L. Bevins Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin Nature 422 2003 522 526
90. A.F. Gombart, N. Borregaard, and H.P. Koeffler Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 FASEB J. 19 2005 1067 1077
91. T.-T. Wang, F.P. Nestel, V.r. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J.H. Hanrahan, S. Mader, and J.H. White Cutting edge: 1,25-dihydroxyvitamin D3 expression The J. Immunol. 173 2004 2909 2912
92. J. Schauber, R.A. Dorschner, A.B. Coda, A.S. Büchau, P.T. Liu, D. Kiken, Y.R. Helfrich, S. Kang, H.Z. Elalieh, and A. Steinmeyer Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism J. Clin. Invest. 117 2007 803 811
93. C. Peyssonnaux, V. Datta, T. Cramer, A. Doedens, E.A. Theodorakis, R.L. Gallo, N. Hurtado-Ziola, V. Nizet, and R.S. Johnson HIF-1α expression regulates the bactericidal capacity of phagocytes J. Clin. Invest. 115 2005 1806 1815
94. C. Peyssonnaux, A.T. Boutin, A.S. Zinkernagel, V. Datta, V. Nizet, and R.S. Johnson Critical role of HIF-1α in keratinocyte defense against bacterial infection J. Invest. Derm. 128 2008 1964 1968
95. J. Rius, M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, R.S. Johnson, G.G. Haddad, and M. Karin NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha Nature 453 2008 807 811
96. C.Y.M. Okumura, A. Hollands, D.N. Tran, J. Olson, S. Dahesh, M. von Köckritz-Blickwede, W. Thienphrapa, C. Corle, S.N. Jeung, and A. Kotsakis A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection J. Mol. Med. 90 2012 1079 1089
97. S. Dohrmann, S. Anik, J. Olson, E.L. Anderson, N. Etesami, H. No, J. Snipper, V. Nizet, C.Y. Okumura Role for streptococcal collagen-like protein 1 in M1T1 group A Streptococcus resistance to neutrophil extracellular traps Infect. Immun. 82 2014 4011 4020